Treatment and Prevention of Neurocristopathies

Trends Mol Med. 2021 Feb 22:S1471-4914(21)00041-1. doi: 10.1016/j.molmed.2021.01.009. Online ahead of print.ABSTRACTNeurocristopathies form a heterogeneous group of rare diseases caused by abnormal development of neural crest cells. Heterogeneity of neurocristopathies directly relates to the nature of these migratory and multipotent cells, which generate dozens of specialized cell types throughout the body. Neurocristopathies are thus characterized by congenital malformations of tissues/organs that otherwise appear to have very little in common, such as the craniofacial skeleton and enteric nervous system. Treatment options are currently very limited, mainly consisting of corrective surgeries. Yet, as reviewed here, analyses of normal and pathological neural crest development in model organisms have opened up the possibility for better treatment options involving cellular and molecular approaches. These approaches provide hope that some neurocristopathies might soon be curable or preventable.PMID:33627291 | DOI:10.1016/j.molmed.2021.01.009
Source: Trends in Molecular Medicine - Category: Molecular Biology Authors: Source Type: research